As we advance our mission to develop breakthrough therapies that fundamentally change the way we treat, prevent, and control progressive and infectious respiratory diseases, we regularly share the progress of our research.

To learn more about our science and research findings, download the PDFs below:

ACAAI – 2018 – A Phase 1/1B Study of an Inhaled Formulation of Itraconazole in Healthy Volunteers and Asthmatics